# BioLineRx Ltd.: Form SC 13D, filed Oct 26, 2023

- Company: [BioLineRx Ltd.](/companies/blrx.md) (CIK 1498403)
- Form: SC 13D
- Filed: 2023-10-26
- Accepted by EDGAR: Oct 26, 2023, 18:18 ET
- Period: not reported
- Accession: 0001178913-23-003401
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1498403/000117891323003401/zk2330427.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1498403/000117891323003401/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1498403/000117891323003401/zk2330427.htm

Filed Oct 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001178913-23-003401. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
